Under the agreement, the two companies will work to develop affinity-based products for use in the production processes for protein-based pharmaceuticals. The development of these products will be based on Affibodies™, a novel class of small, robust affinity proteins designed to bind desired protein targets. Financial details of the agreement were not disclosed.
“The use of Affibodies™ opens up new possibilities for large-scale protein purification for production of protein based pharmaceuticals. We are very pleased that we can continue to build value through our successful collaboration with Affibody”, said Peter Ehrenheim, Vice President of Protein Separations at Amersham Biosciences.
Affibody and Amersham Biosciences have a successful ongoing collaboration, which was initiated two years ago. For Amersham Biosciences, the newly initiated collaboration entails an expansion of the Company’s research portfolio regarding products for purification, i.e. affinity chromatography.
“The agreement validates the commercial value of Affibody’s technology and is an important milestone for us. This also shows that Affibody is an attractive business partner. Our collaboration with Amersham Biosciences has been very fruitful so far, and has already resulted in royalty revenues,” says Torben Jørgensen, CEO of Affibody.
Torben Jørgensen | Source: alphagalileo
Further information: www.affibody.com
More articles from Life Sciences:
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | NOAA Fisheries Northeast Fisheries Science Center
Texas A&M Researchers Examine How Viruses Destroy Bacteria
20.11.2009 | Texas A&M University
Scientists Unravel Evolution of Highly Toxic Box Jellyfish
20.11.2009 | Life Sciences
When good companies do bad things: Examining illegal corporate behavior
20.11.2009 | Business and Finance
UCR plant scientist's research spawns new discoveries showing how crops survive drought
20.11.2009 | Agricultural and Forestry Science
Multidisciplinary meeting on Urological Cancers aims to benefit cancer patients
20.11.2009 | Event News
'Golden Age' for clinical psychology in Northern Ireland
20.11.2009 | Event News
New Perspectives in Marine Anti-Fouling Research
11.11.2009 | Event News